| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01198535 NCT01207882 Details | 2015-05-18 Interventional | 1 | 60 | 2,2-dimethyl-N-… Antibodies Antibodies, Mon… Antineoplastic … Cetuximab Gamma Secretase… Immunoglobulins Adenocarcinoma Adenocarcinoma,… Carcinoma Carcinoma, Sign… Colonic Neoplas… Cystadenocarcin… Rectal Neoplasm… Recurrence Colon Mucinous … Colon Signet Ri… Rectal Mucinous… Rectal Signet R… Recurrent Colon… Recurrent Recta… Stage IVA Colon… Stage IVA Recta… Stage IVB Colon… Stage IVB Recta… | - - | |||
| NCT02036528 Details | 2015-05-14 Interventional | 1/2 | 9 | Ciprofloxacin Doxycycline Gentamicins Diabetic Foot Foot Ulcer Ulcer Diabetic Foot U… | - - | |||
| NCT00620659 Details | 2015-05-13 Interventional | 2 | [1 Refs] | 125 | Modafinil Apnea Disorders of Ex… Sleep Apnea Syn… Sleep Apnea, Ob… Sleepiness Syndrome Excessive Dayti… Hypopnea Syndro… | - - | ||
| NCT01863225 Details | 2015-05-12 Interventional | 2 | 13 | Atorvastatin Rosuvastatin Ca… Coronary Artery… Dyslipidemias Dyslipidemia | - - | |||
| NCT00525941 Details | 2015-05-12 Interventional | 3 | 0 | Indiplon Sleep Initiatio… Insomnia | Study discontinued due to Approvable decision - | |||
| NCT01637545 Details | 2015-05-08 Interventional | 4 | 49 | Ramosetron Facies Fractures, Bone Skull Fractures Facial Bones Fr… | Principal Investigator is away on business - | |||
| NCT00666497 Details | 2015-05-08 Interventional | 2 | 6 | Azacitidine Mocetinostat Leukemia Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Preleukemia Syndrome Acute Myeloid L… Myelodysplastic… | Celgene terminated its collaboration agreement with MethylGene for the development of MGCD0103.
All Celgene-sponsored trials with MGCD0103 with be closed. - | |||
| NCT01496430 Details | 2015-05-06 Interventional | 3 | 105 | Azilsartan medo… Diabetes Mellit… Hypertension Diabetes | Business Decision; No Safety Or Efficacy Concerns. (See below) Because of low enrollment in the study, the sample sizes in the results data do not allow for significant interpretation of the results. | |||
| NCT00984152 Details | 2015-05-06 Interventional | 3 | 0 | Efavirenz Efavirenz, Emtr… Raltegravir Pot… HIV-1 Infection… | Decision not to go forth with study. - | |||
| NCT00088907 NCT00695760 Details | 2015-05-06 Interventional | 3 | [1 Refs] | 270 | Docetaxel Gefitinib Head and Neck N… Metastatic Head… Recurrent Head … | It was unlikely that the primary endpoint would be reached based on the fifth interim analysis
results. - | ||
| NCT01757691 2012-002968-27 Details | 2015-05-04 Interventional | 2 | 2 | Fingolimod Hydr… Neuritis Optic Neuritis Acute Demylelin… | Discontinuation of this study was based on Novartis decision to discontinue development of
fingolimod for the treatment of ADON - | |||
| NCT01389856 Details | 2015-05-01 Interventional | 3 | 23 | Bosentan Hypertension Hypertension, P… Persistent Feta… Persistent Pulm… | To be compliant with the timelines as agreed with Paediatric Committee (PC) within the
Paediatric Investigational Plan - | |||
| NCT00395967 Details | 2015-05-01 Interventional | 2 | 5 | Plerixafor Lymphoma Lymphoma, Non-H… Multiple Myelom… Neoplasms, Plas… Lymphoma, Non-H… | Enrollment terminated in 2005 to focus on Phase 3 study enrollment. Limited enrollment due to early termination of the study. | |||
| NCT00109538 Details | 2015-05-01 Interventional | 3 | 47 | Lonafarnib Leukemia Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Preleukemia Syndrome Myelodysplasia Myelomonocytic | - - | |||
| NCT01148901 2009-016587-36 Details | 2015-04-30 Interventional | 4 | 0 | Infliximab Arthritis Spondylarthriti… Spondylitis Spondylitis, An… Ankylosing Spon… | No patient enrolled after 6 months from the start. The decision to withdraw the study was based
on a feasibility reevaluation conducted with investigators. - | |||
| NCT02213653 Details | 2015-04-29 Interventional | 4 | 24 | Iron Anemia, Iron-De… Iron Deficienci… Neoplasm Metast… Lymphoid Diseas… Solid Cancer Me… | - - | |||
| NCT00459901 Details | 2015-04-29 Interventional | 2 | 13 | Capecitabine Erlotinib Hydro… Colorectal Neop… Metastatic Colo… | Study halted by drug manufacturer - | |||
| NCT01981811 Details | 2015-04-28 Interventional | 2 | 0 | Aripiprazole Mental Disorder… Nervous System … Schizophrenia Bipolar 1 Disor… Mental Disorder | The trial was terminated because it was determined that the usability of the MIND1 System in
the intended population was necessary before conducting this trial. - | |||
| NCT01561404 2009-010541-31 Details | 2015-04-28 Interventional | 4 | 3 | Everolimus Disorder Relate… Exercise, Aerob… Muscle Strength | lack of potential patients - | |||
| NCT00385450 Details | 2015-04-28 Interventional | 1 | 41 | Nelfinavir Lymphopenia Cardiopulmonary… | Study closed at Mayo prior to completion - |